James Spicer

MB BS, Phd, King's College London, US

Specializes in [Drug Development]

Professor of Experimental Cancer Medicine in the School of Cancer & Pharmaceutical Studies at King’s College London and Consultant in Medical Oncology at Guy’s & St Thomas’ Hospitals
Leads Guy’s Phase I Cancer Trials programme and National Institute for Health Research Senior Investigator
Co-founder of Epsilogen & Aethox Therapeutics